This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell…
- Investigator
- Jonathan A Chatzkel
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All